
The fraudster, who was sentenced to several years in prison, is to be transferred to a rehabilitation facility.
AI-generated summary
Elizabeth Holmes deceived investors with her start-up Theranos and was sentenced to prison and paying damages.
Holmes deceived investors by promising that her startup could perform many medical tests with a single drop of blood. In the meantime, Theranos, as the company was called, was valued at around nine billion dollars; Holmes himself is worth around $4.5 billion.
But the supposed success story was nothing more than a hoax. Instead of innovations, the company apparently simply used conventional testing procedures. A US court sentenced her to more than eleven years in prison for fraud. She also had to pay $452 million in damages.
However, her prison sentence was reduced several times. According to prison documents, reported by the Guardian among others, Holmes is scheduled to be released in February 2030. According to US media, those affected by their fraud have now been informed about the planned move to the rehabilitation facility in Del Valle, Texas. Holmes herself is said to imagine her future in Austin.
The case of the fraudulent self-made billionaire who embodied the American Dream has so many layers that a documentary was made about her. “You Can See Everything” from the production company A24 is scheduled to be released in cinemas on October 16th and the trailer has already caused a stir (read more about it here).
AI outlook — possibilities, not facts
Dismissal of Elizabeth Holmes in February 2030
Likely · Within months

Former Amazon executives have analyzed 20 management techniques of the US company in the book “The Secret Playbook”. The Handelsblatt exclusively highlights which methods can be successfully transferred to other companies and what the limits are.

The Düsseldorf-based insurance group Ergo is appointing the head of its US subsidiary Next Insurance, Guy Goldstein, to the board as Chief Artificial Intelligence Officer on October 1st. He replaces Mark Klein, who is leaving the company.

Novo Nordisk's capital market day in London disappoints investors despite plans for new blockbusters by 2030. The share continues to lose value, while US competitor Eli Lilly dominates with strong profit growth.

UBS Real Estate GmbH handles the open real estate fund UBS Euroinvest for German private investors. The reason for the termination on September 24th are ongoing challenges in the European real estate market and ongoing capital withdrawals.
Philipp Nimmermann is the first Green Party politician to join the Bundesbank board. The Federal Council voted for the former State Secretary for Economic Affairs as Burkhard Balz's successor in the six-member committee.

Handelsblatt examines the topic of passive income from a psychological and financial perspective. Using expert interviews and calculation examples, the illusions of early retirement and four investment strategies for a steady stream of money are explained.